EO-2040

N/A

Report date: 2024/12/25 20:00:50

Base Information

Drug NameEO-2040

Drug Alias NameEO-2040

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesEnterome

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEnterome

Active IndicationsN/A

Inactive IndicationsColorectal Neoplasms

ATC CodeN/A